Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

April 30, 2008

Rituxan ( Vitamin R ): Let's not panic!!

Analysis of: Wider Aim for Rituxan Fails | online.wsj.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Kenneth Algazy, MD, Clinical Professor of Medicine , University of Pennsylvania School of Medicine - CCKenneth Algazy, MD 
Clinical Professor of Medicine , University of Pennsylvania School of Medicine - CC
Implications: Rituxan failed to improve various parameters and targets in a rather comprehensive study of patients with Lupus.

Analysis: Let's not panic!! I have not seen the data but there may be some subsets that benefit, so wait for a complete analysis. In addition as a hematologist/oncologist we use Rituxan in any disorder that is of an immune nature whether neoplastic or benign. These include besides lymphomas, coagulation disorders and immune thrombocytopenia. The market may be reduced but there are still multiple uses that remain to be explored


Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics